Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

357

HTML

2431

Figures (1-1)

228

Tables (1-2)

210

Sum=3226

Oct 28, 2012 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 28, 2012; 18(40): 5793-5798
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5793

Table 1 Baseline characteristics of patients (n = 238)

Continuous variables (mean ± SD)
Age (yr)	29 ± 8.5
Hemoglobin (g/dL)	11.49 ± 2.45
The mean platelet count (10³/mm³)	145.6 ± 14.3
SGPT (IU/L)	134.18 ± 14.3
Hepatitis B DNA level (IU/mL)	155 × 10³± 70.1 × 10³
Categorical variable, frequency (%)
Sex
Male	180 (75.6)
Female	58 (24.4)
Stage of fibrosis
Stage 2	172 (72.3)
Stage 3	44 (18.5)
Stage 4	22 (9.2)
Biochemical response	122 (51.3)
End of treatment	71 (29.8)
Sustained viral response	70 (29.4)

SGPT: Serum glutamic pyruvic transaminase.

Citation: Samiullah S, Bikharam D, Nasreen. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response. World J Gastroenterol 2012; 18(40): 5793-5798
URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5793.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i40.5793